Medicaid plans aren’t required to cover Wegovy for weight loss and obesity, but some do and others are considering adding…
Read More »Wegovy
An estimated 3.6 million Medicare beneficiaries could potentially access Wegovy now that the Food and Drug Administration (FDA) approved the…
Read More »Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked…
Read More »Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart failure symptoms for patients with diabetes in the latest large…
Read More »Wegovy, a semaglutide medication, will be covered by Medicare. George Frey/Bloomberg via Getty Images hide caption toggle caption George Frey/Bloomberg…
Read More »While the program won’t cover the drug for weight loss, the decision could still open access and provide a potential…
Read More »Ozempic is often used to treat type 2 diabetes, but it might also lower the risk of cannabis use disorder…
Read More »Ozempic can help people to quickly lose weight but may also have serious side effects Ute Grabowsky/imageBROKER/Shutterstock Ozempic and Wegovy…
Read More »JHVEPhoto/iStock Editorial via Getty Images Novo Nordisk (NVO) shares on Wednesday reached an all-time high as it reported a strong…
Read More »New weight-loss drugs may bypass the need to inject Richard Levine/Alamy It may feel like there has been a stream…
Read More »